N-acetyl-D-mannosamine

N-乙酰-D-甘露糖胺

Report date: 2026/02/18 20:02:09
NME

Base Information

Drug NameN-acetyl-D-mannosamine
Drug Alias NameN-acetyl-mannosamine2-Actamido-2-deoxy-D-mannoseOral N-acetyl-D-mannosamineD-ManNAcManNAc +[9] 
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionGlycosylation stimulantsProteins modulators
TargetsProteins
Therapy Area/IndicationsHereditary inclusion body myopathy (HIBM)Glomerulosclerosis, Focal SegmentalKidney Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNational Human Genome Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of HealthLeadiant BiosciLeadiant Biosciences Inc +[4] 
Inactive CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
Active IndicationsHereditary inclusion body myopathy (HIBM)Glomerulosclerosis, Focal SegmentalDistal Myopathies
Inactive IndicationsKidney Diseases

Other Information

ATC CodeN/A
Related LinksN/A